Skip to main content

Table 4 Mean (SD) health utility, Quality Adjusted Life Years (QALYs) and costs

From: Clinical and cost effectiveness of arthritis gloves in rheumatoid arthritis (A-GLOVES): randomised controlled trial with economic analysis

  Control Intervention
EQ-5D-3L Baseline n = 103 12-week follow-up n = 79 Change n = 79 Baseline n = 103 12-week follow-up n = 84 Change n = 84
Utility (Mean, SD) 0.44 (0.37) 0.55 (0.55) 0.09 (0.27) 0.44 (0.34) 0.54 (0.31) 0.05 (0.26)
QALYs (Mean, SD) 0.12 (0.07) 0.12 (0.07)
Costs during follow-up (Mean, SD)
 Outpatient £255 (268) (n = 78) £317 (333) (n = 82)
 Primary and community care £59 (86) (n = 75) £66 (101) (n = 81)
 Intervention £0 £129 (n = 78)
TOTALa £391 (543) (n = 75) £552 (464) (n = 78)
  1. a Total cost includes inpatient admissions, day case visits, and A&E visits. The mean intervention cost is reported for participants with complete cost data. Intervention cost comprised of actual number of compression gloves provided per participant costing £31.43/glove (NHS dispensing costs) and one visit to a secondary care occupational therapist costing £65.85 (NHS reference costs)